The Trump administration is continuing its push to revise federal guidelines to delay the hepatitis B vaccine newborn dose for most children.
In hepatitis B vaccine debate, CDC panel sidesteps key exposure risk
- Post author:admin
- Post published:
- Post category:uncategorized